J1558 HCPCS code: Injection, immune globulin (xembify), 100 mg
J1558 is the HCPCS Level II code for injection, immune globulin (xembify), 100 mg. In 2024 Medicare paid an average of $11.15 per service for J1558 across 2,730,097 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1500 per day on DME suppliers. Medicare volume rose 39% from 2022 to 2024 (1,966,729 to 2,730,097 services). In 2024, 153 suppliers billed Medicare for J1558 (purchases), serving 747 beneficiaries; Georgia, Florida, California accounted for 34% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2020-07-01 |
| Last action effective | 2020-07-01 |
Who bills J1558 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 153 |
| Referring clinicians | 492 |
| Medicare beneficiaries | 747 |
| States with claims | 39 |
| Share of services in top 3 states (Georgia, Florida, California) | 34% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 97 | 496 |
| 2023 | 120 | 601 |
| 2024 | 153 | 747 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1558, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,966,729 | 496 | $13.58 | $10.70 |
| 2023 | 2,333,998 | 601 | $13.65 | $10.68 |
| 2024 | 2,730,097 | 747 | $14.25 | $11.15 |
States with the most J1558 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Georgia | 463,910 | $11.13 |
| Florida | 224,420 | $11.16 |
| California | 222,490 | $11.16 |
| Texas | 174,964 | $11.16 |
| North Carolina | 122,090 | $11.16 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 1500 | Clinical: CMS Workgroup |
| outpatient hospital claims | 480 | Prescribing Information |
| practitioner claims | 480 | Prescribing Information |
Medicare policy articles for this code
- A52507: External Infusion Pumps - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC)) — mentions this code in its coding guidance
- A56786: Billing and Coding: Immune Globulin (Novitas Solutions, Inc. (MAC - Part A, MAC - Part B))
- A57778: Billing and Coding: Immune Globulin (First Coast Service Options, Inc. (MAC - Part A, MAC - Part B))
Covered diagnoses (542 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| D80.0 | Hereditary hypogammaglobulinemia | 3 |
| D80.2 | Selective deficiency of immunoglobulin A [IgA] | 3 |
| D80.3 | Selective deficiency of immunoglobulin G [IgG] subclasses | 3 |
| D80.4 | Selective deficiency of immunoglobulin M [IgM] | 3 |
| D80.5 | Immunodeficiency with increased immunoglobulin M [IgM] | 3 |
| D80.6 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia | 3 |
| D80.7 | Transient hypogammaglobulinemia of infancy | 3 |
| D81.0 | Severe combined immunodeficiency [SCID] with reticular dysgenesis | 3 |
| D81.1 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers | 3 |
| D81.2 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers | 3 |
Showing 10 of 542. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for J1558
- 2020-07-01: J1558 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1558?
J1558 is the HCPCS Level II code for injection, immune globulin (xembify), 100 mg. Short descriptor: "Inj. xembify, 100 mg".
How much does Medicare pay for J1558?
In 2024, the average Medicare payment was $11.15 per service (average allowed $14.25).
Does Medicare cover J1558?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for J1558?
Medicare policy articles that cite J1558 list 542 covered ICD-10-CM diagnosis codes across 3 articles. The most cited include D80.0 (Hereditary hypogammaglobulinemia), D80.2 (Selective deficiency of immunoglobulin A [IgA]), D80.3 (Selective deficiency of immunoglobulin G [IgG] subclasses). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J1558 can be billed per day?
1500 on DME suppliers; 480 on outpatient hospital claims; 480 on practitioner claims (NCCI medically unlikely edits).
Related J15 codes
- J1551 — Injection, immune globulin (cutaquig), 100 mg
- J1552 — Injection, immune globulin (alyglo), 500 mg
- J1553 — Injection, immune globulin (yimmugo), 100 mg
- J1554 — Injection, immune globulin (asceniv), 500 mg
- J1555 — Injection, immune globulin (cuvitru), 100 mg
- J1556 — Injection, immune globulin (bivigam), 500 mg
- J1557 — Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1559 — Injection, immune globulin (hizentra), 100 mg
- J1560 — Injection, gamma globulin, intramuscular, over 10 cc
- J1561 — Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1562 — Injection, immune globulin (vivaglobin), 100 mg
- J1566 — Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1558
- Watch J1558 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1558
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.